To Top

Community

Doug Krafte, Ph.D.

Doug Krafte is currently the Chief Scientific Officer at Icagen, Inc. Dr. Krafte has held a variety of positions over 25 years within the pharma / biotech sectors across multiple therapeutic areas, most recently as Executive Director & Site Head for the US arm of Pfizer’s Pain & Sensory Disorders Research Unit, as well as positions at Aurora Biosciences, Boehringer Ingelheim and Sterling Winthrop.

Contribution
Innovation

Developing Targeted Potassium Channel Openers for CNS-Related Therapeutics

PAP-Q4-17-CL-004